Hawaii 2022 Regular Session

Hawaii Senate Bill SR145

Introduced
3/11/22  

Caption

Requesting The Auditor To Assess The Social And Financial Effects Of Mandating Health Insurance Coverage For Oocyte Cryopreservation.

Impact

If passed, SR145 would instruct the Auditor to conduct a detailed assessment as required under Hawaii Revised Statutes sections 23-51 and 23-52. The Auditor's evaluation would analyze both the social ramifications of infertility treatment accessibility and the financial considerations of requiring insurance companies to cover the cost of oocyte cryopreservation. This could potentially expand women's reproductive healthcare options and address infertility issues linked to medical treatments or genetic predispositions.

Summary

Senate Resolution 145 (SR145) seeks to assess the social and financial implications of mandating health insurance coverage for oocyte cryopreservation procedures, often referred to as egg freezing. This resolution arises from concerns regarding women's healthcare, particularly for those undergoing treatments like chemotherapy, which significantly increase the risk of infertility. The need for such coverage has prompted legislative interest, specifically referencing Senate Bill No. 2917 introduced during the Regular Session of 2022, which calls for this specific health insurance mandate.

Conclusion

Ultimately, SR145 stands at the intersection of women's health rights and financial policy within the healthcare sector. The expected findings of the Auditor's assessment will be crucial in determining the feasibility and advisability of implementing a mandated coverage for oocyte cryopreservation, reflecting broader societal values about reproductive health and insurance obligation.

Contention

While the resolution supports increased healthcare access for women facing infertility challenges, potential points of contention may arise regarding the financial impacts on health insurance providers and how these changes could influence premiums and costs for consumers. Stakeholders may debate the extent of legislative power in healthcare decisions, questioning whether mandating such coverage is in the best interest of the insurance model overall and whether it opens the door to further mandates of this nature.

Companion Bills

HI SCR152

Same As Requesting The Auditor To Assess The Social And Financial Effects Of Mandating Health Insurance Coverage For Oocyte Cryopreservation.

Similar Bills

HI HCR28

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.

CT HB05230

An Act Requiring Health Insurance Coverage For Fertility Preservation For Insureds Diagnosed With Cancer.

CT HB05968

An Act Requiring Health Insurance Coverage For Fertility Preservation For Insureds Diagnosed With Cancer.

HI SCR241

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.

LA HB689

Provides for coverage for fertility preservation for individuals diagnosed with cancer (EG INCREASE GF EX See Note)

HI SCR152

Requesting The Auditor To Assess The Social And Financial Effects Of Mandating Health Insurance Coverage For Oocyte Cryopreservation.

CT HB05245

An Act Requiring Health Insurance Coverage For Fertility Preservation For Cancer Patients.

CT HB05500

An Act Requiring Health Insurance Coverage For Fertility Preservation For Insureds Diagnosed With Cancer.